Phreesia (NYSE:PHR) General Counsel Sells $67,152.96 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison Hoffman sold 6,662 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the completion of the sale, the general counsel owned 266,574 shares of the company’s stock, valued at approximately $2,687,065.92. This trade represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Phreesia Price Performance

PHR opened at $10.01 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $24.25. The stock has a market capitalization of $621.07 million, a PE ratio of 58.86 and a beta of 0.86. The stock’s 50 day moving average price is $11.10 and its 200-day moving average price is $10.27.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The business had revenue of $129.46 million during the quarter, compared to analysts’ expectations of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.01 EPS. On average, equities research analysts predict that Phreesia, Inc. will post 0.33 EPS for the current year.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the business. Sequoia Financial Advisors LLC bought a new position in shares of Phreesia in the 2nd quarter worth about $159,000. Integrated Wealth Concepts LLC boosted its stake in Phreesia by 37.2% during the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company’s stock worth $145,000 after acquiring an additional 3,834 shares in the last quarter. Allworth Financial LP grew its holdings in Phreesia by 78.3% in the second quarter. Allworth Financial LP now owns 5,613 shares of the company’s stock worth $58,000 after purchasing an additional 2,465 shares during the period. Corient Private Wealth LP grew its holdings in Phreesia by 451.7% in the second quarter. Corient Private Wealth LP now owns 148,290 shares of the company’s stock worth $1,526,000 after purchasing an additional 121,413 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Phreesia during the second quarter valued at approximately $1,038,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on PHR. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research note on Friday, September 4th. Canaccord Genuity Group restated a “buy” rating and issued a $16.00 price objective on shares of Phreesia in a report on Thursday, September 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $19.00 price objective on shares of Phreesia in a research report on Thursday, September 3rd. Needham & Company LLC reiterated a “buy” rating and set a $14.00 target price on shares of Phreesia in a report on Monday, August 31st. Finally, Raymond James Financial lowered Phreesia from an “outperform” rating to a “market perform” rating in a research report on Tuesday, September 8th. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Phreesia presently has a consensus rating of “Hold” and a consensus target price of $14.00.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems.

The company’s offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing.